Cbl-b Deficiency Mediates Resistance to Programmed Death-Ligand 1/Programmed Death-1 Regulation.
about
Cblb-deficient T cells are less susceptible to PD-L1-mediated inhibition.Lys63-polyubiquitination by the E3 ligase casitas B-lineage lymphoma-b (Cbl-b) modulates peripheral regulatory T cell tolerance in patients with systemic lupus erythematosus.Targeted Tumor Therapy Remixed-An Update on the Use of Small-Molecule Drugs in Combination Therapies.Multi-faceted immunomodulatory and tissue-tropic clinical bacterial isolate potentiates prostate cancer immunotherapy.
P2860
Cbl-b Deficiency Mediates Resistance to Programmed Death-Ligand 1/Programmed Death-1 Regulation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cbl-b Deficiency Mediates Resi ...... Programmed Death-1 Regulation.
@en
Cbl-b Deficiency Mediates Resi ...... Programmed Death-1 Regulation.
@nl
type
label
Cbl-b Deficiency Mediates Resi ...... Programmed Death-1 Regulation.
@en
Cbl-b Deficiency Mediates Resi ...... Programmed Death-1 Regulation.
@nl
prefLabel
Cbl-b Deficiency Mediates Resi ...... Programmed Death-1 Regulation.
@en
Cbl-b Deficiency Mediates Resi ...... Programmed Death-1 Regulation.
@nl
P2860
P356
P1476
Cbl-b Deficiency Mediates Resi ...... Programmed Death-1 Regulation.
@en
P2093
Emily J Anstadt
Robert B Clark
P2860
P356
10.3389/FIMMU.2017.00042
P50
P577
2017-01-26T00:00:00Z